Filing Details
- Accession Number:
- 0001127602-18-006007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-14 14:32:55
- Reporting Period:
- 2018-02-12
- Accepted Time:
- 2018-02-14 14:32:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222831 | A Glenn Eisenberg | 531 South Spring Street Burlington NC 27215 | Chief Financial Officer, Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-12 | 6,300 | $167.16 | 15,931 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 1,600 | $167.78 | 14,331 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 500 | $168.61 | 13,831 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Acquisiton | 2018-02-12 | 9,100 | $0.00 | 9,100 | $168.49 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2018-02-12 | 2,340 | $0.00 | 2,340 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,100 | 2019-02-12 | 2028-02-11 | No | 4 | A | Direct |
| 10,831 | No | 4 | A | Direct |
Footnotes
- The price of $167.1570 per share represents a weighted average of sales prices ranging from $166.58 to $167.53 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $167.7775 per share represents a weighted average of sales prices ranging from $167.59 to $168.58 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $168.6140 per share represents a weighted average of sales prices ranging from $168.59 to $168.68 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- The option vests in three equal installments beginning on the date reflected in this column.
- Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2019.
- This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Billionaire Hedge Funds
